Back to Search
Start Over
In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease.
- Source :
-
Antiviral research [Antiviral Res] 2004 Jun; Vol. 62 (3), pp. 111-20. - Publication Year :
- 2004
-
Abstract
- Inhibition of ribonucleotide reductase (RR) has gained attention as a potential strategy for HIV-1 therapy through the success of hydroxyurea (HU) to potentiate the activity of the nucleoside reverse transcriptase inhibitor (NRTI) didanosine (ddI) in clinical trials. However, the use of HU has been limited by its development of hematopoietic toxicity. In this study, the novel RR inhibitors didox (DX; 3,4-dihydroxybenzohydroxamic acid), and trimidox (TX; 3,4,5-trihydroxybenzamidoxime) were evaluated along with HU for anti-retroviral efficacy in LPBM5-induced retro-viral disease (MAIDS) both as monotherapeutic regimens and in combination with the guanine containing NRTI abacavir (ABC). Anti-retroviral drug efficacy was determined by measuring inhibition of splenomegaly, hypergammaglobulinemia, and splenic levels of proviral DNA. In this study, all RRIs tested showed the ability to improve the efficacy of ABC in the MAIDS model by reducing splenomegaly, hypergammaglobulinemia, and splenic proviral DNA levels.
- Subjects :
- Animals
Antiviral Agents pharmacology
Benzamidines therapeutic use
Dideoxynucleosides therapeutic use
Disease Models, Animal
Drug Therapy, Combination
Hematopoietic Stem Cells drug effects
Hydroxamic Acids therapeutic use
Hydroxyurea adverse effects
Hydroxyurea chemistry
Mice
Mice, Inbred C57BL
Murine Acquired Immunodeficiency Syndrome blood
Murine Acquired Immunodeficiency Syndrome immunology
Murine Acquired Immunodeficiency Syndrome pathology
Spleen pathology
Splenomegaly
Antiviral Agents therapeutic use
Bone Marrow Cells drug effects
Hydroxyurea therapeutic use
Murine Acquired Immunodeficiency Syndrome drug therapy
Ribonucleotide Reductases antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 0166-3542
- Volume :
- 62
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Antiviral research
- Publication Type :
- Academic Journal
- Accession number :
- 15130534
- Full Text :
- https://doi.org/10.1016/j.antiviral.2003.11.007